Dial Schedule M: India’s drug manufacturing practices to undergo major overhaul by Lexplosion | Feb 28, 2024 | Compliance, Legal analysis, PharmaceuticalsIf you are a pharmaceutical company in India with a turnover of more than Rs. 250 crores, you only... Read More
ICSI revises Secretarial Standards for Board and General Meetings in conformity with Companies Act, 2013, Effective April 1, 2024 by Lexplosion | Feb 22, 2024 | Compliance, Legal analysisWith a view to align the secretarial standards with the provisions of the Companies Act, 2013 (Act... Read More
Compulsory insurance under Payment of Gratuity Act in Karnataka: What You Need to Know? by Lexplosion | Feb 20, 2024 | Compliance, Karnataka, Legal analysisIf you are an existing employer operating from Karnataka, chances are that you need to obtain an... Read More
Framework for SEBI Regulated Entities to mitigate risks from cloud services by Lexplosion | Feb 20, 2024 | Compliance, Legal analysis, SEBIIf you are a SEBI Regulated Entity (“RE”),[1] – a depository, a depository participant or an... Read More
Payment Banks and Ways to Steer Clear from RBI’s Wrath – The Regulatory Regime by Lexplosion | Feb 13, 2024 | Compliance, Legal analysis, NBFCReams have already been written on the RBI’s recent decision to impose stringent strictures on... Read More